We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




CDI Risk Higher in Subsequent Hospital Bed Patients

By HospiMedica International staff writers
Posted on 26 Oct 2016
Hospital patients who followed a prior bed occupant that received antibiotics had an increased risk for contracting Clostridium difficile infection (CDI), according to a new study.

Researchers at New York-Presbyterian Hospital/Columbia University Medical Center (NYP; New York, NY, USA) and Columbia University Medical Center (CUMC, New York, NY, USA) conducted a retrospective cohort study of 100,615 paired adult patients hospitalized between 2010 and 2015. More...
Patients were excluded if they had recent CDI, developed CDI within 48 hours of admission, had inadequate follow-up time, or if their prior bed occupant was in the bed for less than 24 hours.

The primary exposure was receipt of antibiotics by the prior bed occupant, and the primary outcome was incident CDI in the subsequent patient to occupy the same bed, defined as a positive result from a stool polymerase chain reaction (PCR) for the C difficile toxin B gene, followed by treatment for CDI. In all, 576 (0.57%) of the secondary patients developed CDI within 2 to 14 days, representing a 22% hazard ratio after adjustment for CDI risk factors, including receipt of antibiotics by the second patient. The study was published on October 10, 2016, in JAMA Internal Medicine.

“These data imply that patient-to-patient transmission of C. difficile or other bacteria that mediate susceptibility to CDI takes place in the non-outbreak setting and in the face of a multifaceted effort seeking to prevent healthcare-associated CDI,” concluded lead author Daniel Freedberg, MD, MSc, of NYP, and colleagues. “Antibiotics may affect the gastrointestinal microbiome more globally to decrease bacterial species that are protective against C. difficile or to increase bacterial species that facilitate C. difficile. Subsequent patient-to-patient transmission of these bacterial species may then drive risk for CDI in future patients.”

CDI is a serious illness resulting from infection of the internal lining of the colon by C. difficile bacteria, and typically develops after the use of broad-spectrum antibiotics that disrupt normal bowel flora. C. difficile exists in the environment as a dormant spore; to colonize the gut, the spores need to germinate and turn in active, toxin-producing bacteria. Antibiotics that alter gastrointestinal microbiota facilitate this germination, leading to CDI, the leading cause of nosocomial diarrhea in industrialized countries.

Related Links:
New York-Presbyterian Hospital
Columbia University Medical Center

Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: IMX742 CMOS image sensor for single-use endoscopes (Photo courtesy of Sony Semiconductor Solutions Corporation)

Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes

Disposable single-use endoscopes are increasingly used to help reduce infection risk and the burden of post-procedure reprocessing and equipment management. As insertion sections become thinner, endoscopic... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.